Handelsbanken Fonder’s Bristol-Myers Squibb BMY Stock Holding History

Handelsbanken Fonder’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.4M	Sell	910,107 -446,938	-33%	-$25.7M	0.15%	109
2026 Q1	$82.3M	Buy	1,357,045 +87,125	+7%	+$5.08M	0.27%	69
2025 Q4	$68.5M	Buy	1,269,920 +140,901	+12%	+$6.78M	0.21%	85
2025 Q3	$50.9M	Sell	1,129,019 -332,506	-23%	-$15.5M	0.16%	119
2025 Q2	$67.7M	Sell	1,461,525 -23,002	-2%	-$1.13M	0.24%	87
2025 Q1	$90.5M	Buy	1,484,527 +6,956	+0.5%	+$405K	0.37%	54
2024 Q4	$83.6M	Sell	1,477,571 -36,161	-2%	-$2.02M	0.32%	58
2024 Q3	$78.3M	Buy	1,513,732 +614,701	+68%	+$28.8M	0.31%	63
2024 Q2	$37.3M	Sell	899,031 -9,204	-1%	-$412K	0.16%	128
2024 Q1	$49.3M	Sell	908,235 -109,568	-11%	-$5.58M	0.21%	104
2023 Q4	$52.2M	Buy	1,017,803 +2,400	+0.2%	+$126K	0.25%	87
2023 Q3	$58.9M	Buy	1,015,403 +35,281	+4%	+$2.16M	0.33%	59
2023 Q2	$62.7M	Sell	980,122 -43,548	-4%	-$2.92M	0.34%	60
2023 Q1	$71M	Buy	1,023,670 +41,345	+4%	+$2.92M	0.41%	46
2022 Q4	$70.7M	Buy	982,325 +4,004	+0.4%	+$302K	0.44%	45
2022 Q3	$69.5M	Buy	978,321 +198,529	+25%	+$14.4M	0.47%	40
2022 Q2	$60M	Buy	779,792 +136,074	+21%	+$10.4M	0.39%	50
2022 Q1	$47M	Sell	643,718 -10,746	-2%	-$722K	0.26%	88
2021 Q4	$40.8M	Buy	654,464 +38,559	+6%	+$2.26M	0.2%	117
2021 Q3	$36.4M	Buy	615,905 +5,652	+0.9%	+$372K	0.19%	120
2021 Q2	$40.8M	Sell	610,253 -43,497	-7%	-$2.84M	0.21%	105
2021 Q1	$41.3M	Buy	653,750 +6,747	+1%	+$420K	0.23%	93
2020 Q4	$40.1M	Buy	647,003 +8,390	+1%	+$516K	0.24%	97
2020 Q3	$38.5M	Buy	638,613 +19,363	+3%	+$1.17M	0.28%	79
2020 Q2	$36.4M	Buy	+619,250	New	+$37M	0.31%	78
2018 Q4	–	Sell	-51,060	Closed	-$3.17M	–	171
2018 Q3	$3.17M	Sell	51,060 -15,000	-23%	-$890K	0.06%	157
2018 Q2	$3.66M	Sell	66,060 -30,000	-31%	-$1.62M	0.07%	157
2018 Q1	$6.08M	Sell	96,060 -27,000	-22%	-$1.74M	0.12%	140
2017 Q4	$7.54M	Buy	123,060 +14,500	+13%	+$907K	0.17%	115
2017 Q3	$6.92M	Buy	108,560 +23,000	+27%	+$1.34M	0.16%	120
2017 Q2	$4.77M	Hold	85,560	–	–	0.12%	136
2017 Q1	$4.65M	Sell	85,560 -30,000	-26%	-$1.65M	0.13%	123
2016 Q4	$6.75M	Sell	115,560 -25,000	-18%	-$1.37M	0.21%	103
2016 Q3	$7.58M	Sell	140,560 -805	-0.6%	-$51.7K	0.22%	109
2016 Q2	$10.4M	Buy	141,365 +23,000	+19%	+$1.63M	0.43%	75
2016 Q1	$7.56M	Sell	118,365 -210,689	-64%	-$13.3M	0.32%	84
2015 Q4	$22.6M	Buy	+329,054	New	+$21.7M	0.44%	70

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Handelsbanken Fonder's BMY Position: Q2 2026 in Review

Handelsbanken Fonder reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q2 2026, selling an estimated $25.7M and leaving 910,107 shares worth $52.4M. The position accounts for 0.15% of the portfolio, ranked #109.

Handelsbanken Fonder first reported a position in BMY in Q4 2015 and has held it in 37 quarters since. The position peaked at $90.5M in Q1 2025. 1,235 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Handelsbanken Fonder held 910,107 shares of Bristol-Myers Squibb worth $52.4M as of Q2 2026.
Handelsbanken Fonder sold 446,938 Bristol-Myers Squibb shares in Q2 2026, an estimated $25.7M.
Bristol-Myers Squibb made up 0.15% of Handelsbanken Fonder's portfolio in Q2 2026, its #109 holding.
Handelsbanken Fonder first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 37 quarters since.
Handelsbanken Fonder's Bristol-Myers Squibb position peaked at $90.5M in Q1 2025.
1,235 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.